Romano Brothers & Co’s Colgate-Palmolive CL Stock Holding History

Romano Brothers & Co’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,748	Closed	-$138K	–	417
2022 Q4	$138K	Buy	+1,748	New	+$131K	0.02%	336

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Romano Brothers & Co's CL Position: Q1 2023 in Review

Romano Brothers & Co sold out of Colgate-Palmolive (CL) in Q1 2023, closing a stake of 1,748 shares — an estimated $138K sold.

Romano Brothers & Co first reported a position in CL in Q4 2022 and held it in 1 quarter. The position peaked at $138K in Q4 2022. 1,657 funds tracked by Wall St. Rank hold CL as of Q1 2023.

Romano Brothers & Co reported no remaining Colgate-Palmolive position as of Q1 2023 after selling out during the quarter.
Romano Brothers & Co sold 1,748 Colgate-Palmolive shares in Q1 2023, an estimated $138K.
Romano Brothers & Co first reported a position in Colgate-Palmolive in Q4 2022 and held it in 1 quarter.
Romano Brothers & Co's Colgate-Palmolive position peaked at $138K in Q4 2022.
1,657 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2023.

Based on Romano Brothers & Co's 13F filing for Q1 2023, filed 13 Apr 2023.